Bárbara Barros Pereira Lobo, Jamil Pedro de Siqueira Caldas
{"title":"Trends in incidence of neonatal late-onset sepsis in very low birth weight infants: a 15-year Brazilian single center analysis.","authors":"Bárbara Barros Pereira Lobo, Jamil Pedro de Siqueira Caldas","doi":"10.1007/s10096-025-05074-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Multiresistant (MR) bacteria neonatal sepsis has been progressively increasing worldwide, raising the risk of death. This study aimed to evaluate the incidence of late-onset neonatal sepsis (LOS) and the incidence of MR agents in very low birth weight (VLBW) infants in a Brazilian tertiary neonatal unit over 15 years.</p><p><strong>Methods: </strong>This was a retrospective temporal trend study. All VLBW infants admitted from 2006 to 2020 diagnosed with LOS caused by Staphylococcus aureus, Enterococcus spp or Gram-negative bacilli were eligible.</p><p><strong>Results: </strong>During the period, 259/1,575 (16.4%) VLBW infants had confirmed LOS, corresponding to 311 episodes of sepsis, 114 of them by agents of interest. There were 20 episodes of MR bacteria LOS (6.4% of the total confirmed LOS), corresponding to 17.5% of the cases of LOS by the studied agents, and to an incidence of 12.7/1,000 admitted VLBW infants. There was a significant trend towards a reduction in the rate of confirmed LOS (P = 0.010), while the trend of incidence of MR agents' sepsis remained stable (1.3 episodes per year - range 0-4/year). The MR incidence corresponded to 18.4% for S. aureus and 19% for Gram-negative bacilli strains. There were no cases of MR Enterococcus or carbapenemase-producing organisms. The rate of sepsis-related in-hospital death was not statistically different between the MR and non-resistant sepsis groups (15.0 versus 19.1%, P = 1,000).</p><p><strong>Conclusion: </strong>The incidence of confirmed LOS in VLBW infants has shown a downward trend, while the rate of LOS due to MR bacteria has remained low and stable over 15 years.</p>","PeriodicalId":11782,"journal":{"name":"European Journal of Clinical Microbiology & Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Microbiology & Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10096-025-05074-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Multiresistant (MR) bacteria neonatal sepsis has been progressively increasing worldwide, raising the risk of death. This study aimed to evaluate the incidence of late-onset neonatal sepsis (LOS) and the incidence of MR agents in very low birth weight (VLBW) infants in a Brazilian tertiary neonatal unit over 15 years.
Methods: This was a retrospective temporal trend study. All VLBW infants admitted from 2006 to 2020 diagnosed with LOS caused by Staphylococcus aureus, Enterococcus spp or Gram-negative bacilli were eligible.
Results: During the period, 259/1,575 (16.4%) VLBW infants had confirmed LOS, corresponding to 311 episodes of sepsis, 114 of them by agents of interest. There were 20 episodes of MR bacteria LOS (6.4% of the total confirmed LOS), corresponding to 17.5% of the cases of LOS by the studied agents, and to an incidence of 12.7/1,000 admitted VLBW infants. There was a significant trend towards a reduction in the rate of confirmed LOS (P = 0.010), while the trend of incidence of MR agents' sepsis remained stable (1.3 episodes per year - range 0-4/year). The MR incidence corresponded to 18.4% for S. aureus and 19% for Gram-negative bacilli strains. There were no cases of MR Enterococcus or carbapenemase-producing organisms. The rate of sepsis-related in-hospital death was not statistically different between the MR and non-resistant sepsis groups (15.0 versus 19.1%, P = 1,000).
Conclusion: The incidence of confirmed LOS in VLBW infants has shown a downward trend, while the rate of LOS due to MR bacteria has remained low and stable over 15 years.
目的:多重耐药(MR)细菌新生儿脓毒症在世界范围内逐渐增加,增加了死亡风险。本研究旨在评估巴西一个三级新生儿单位15年以上超低出生体重(VLBW)婴儿中迟发性新生儿脓毒症(LOS)的发生率和MR药物的发生率。方法:回顾性时间趋势研究。所有2006年至2020年入院的诊断为金黄色葡萄球菌、肠球菌或革兰氏阴性杆菌引起的LOS的VLBW婴儿均入选。结果:在此期间,1,575例VLBW婴儿中有259例(16.4%)确诊为LOS,对应于311例败血症,其中114例是由感兴趣的药物引起的。有20例MR细菌LOS(占确诊LOS总数的6.4%),对应于所研究病原体的LOS病例的17.5%,发生率为12.7/1,000。确认的LOS发生率有显著的下降趋势(P = 0.010),而MR药物脓毒症发生率的趋势保持稳定(每年1.3次,范围为0-4次/年)。金黄色葡萄球菌和革兰氏阴性杆菌的MR发生率分别为18.4%和19%。没有MR肠球菌或产碳青霉烯酶的生物病例。脓毒症相关住院死亡率在MR组和非耐药脓毒症组之间无统计学差异(15.0% vs 19.1%, P = 1000)。结论:VLBW患儿确诊的LOS发生率呈下降趋势,MR菌所致LOS发生率在15年内保持较低且稳定。
期刊介绍:
EJCMID is an interdisciplinary journal devoted to the publication of communications on infectious diseases of bacterial, viral and parasitic origin.